Every lot published · search any lot number before you order

TRIUMPH-5: The Retatrutide and Tirzepatide Head-to-Head Trial

TRIUMPH-5 is registered as NCT06662383. Its direct comparison tests both treatments in adults with obesity using a shared trial protocol.

TRIUMPH-5: The Retatrutide and Tirzepatide Head-to-Head Trial. A shared protocol for two treatments. Population, Comparator, Outcome. GLP LIFE SCIENCES · RESEARCH BRIEF 35 A shared protocol for two treatments Comparisons PopulationComparatorOutcome
A shared protocol for two treatments. Illustration for this research brief.

A shared protocol for two treatments

The registry lists the planned outcome and study design. Registration and an estimated completion date document the study plan. A results posting or publication is needed to interpret the findings.

How to interpret the evidence

When results become available, review the effect estimate, uncertainty and adverse events. Identify the trial’s population before applying it to broader questions.

Give the strongest weight to studies that randomized both treatments within a shared protocol for the clinical question you are asking.

Sources